Sweden · Delayed Price · Currency is SEK Ligand Pharmaceuticals Statistics
Total Valuation
STO:FRAM.B has a market cap or net worth of SEK 15.04 million. The enterprise value is 5.37 million.
| Market Cap | 15.04M |
| Enterprise Value | 5.37M |
Important Dates
The last earnings date was Friday, August 8, 2025.
| Earnings Date | Aug 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
STO:FRAM.B has 3.62 million shares outstanding.
| Current Share Class | 3.56M |
| Shares Outstanding | 3.62M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 70.85% |
| Owned by Institutions (%) | 25.35% |
| Float | 1.05M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.71 |
| PB Ratio | 16.97 |
| P/TBV Ratio | 16.97 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.99 |
| EV / Sales | 0.97 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.98, with a Debt / Equity ratio of 0.02.
| Current Ratio | 0.98 |
| Quick Ratio | 0.97 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -30.96 |
Financial Efficiency
Return on equity (ROE) is -74.27% and return on invested capital (ROIC) is -36.15%.
| Return on Equity (ROE) | -74.27% |
| Return on Assets (ROA) | -19.13% |
| Return on Invested Capital (ROIC) | -36.15% |
| Return on Capital Employed (ROCE) | -856.21% |
| Revenue Per Employee | 191,621 |
| Profits Per Employee | -186,586 |
| Employee Count | 29 |
| Asset Turnover | 0.22 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -71.23% in the last 52 weeks. The beta is 0.55, so STO:FRAM.B's price volatility has been lower than the market average.
| Beta (5Y) | 0.55 |
| 52-Week Price Change | -71.23% |
| 50-Day Moving Average | 4.54 |
| 200-Day Moving Average | 7.11 |
| Relative Strength Index (RSI) | 40.37 |
| Average Volume (20 Days) | 7,045 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, STO:FRAM.B had revenue of SEK 5.56 million and -5.41 million in losses.
| Revenue | 5.56M |
| Gross Profit | -547,000 |
| Operating Income | -7.59M |
| Pretax Income | -6.78M |
| Net Income | -5.41M |
| EBITDA | -7.37M |
| EBIT | -7.59M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 9.69 million in cash and 16,000 in debt, giving a net cash position of 9.67 million or 2.67 per share.
| Cash & Cash Equivalents | 9.69M |
| Total Debt | 16,000 |
| Net Cash | 9.67M |
| Net Cash Per Share | 2.67 |
| Equity (Book Value) | 886,000 |
| Book Value Per Share | n/a |
| Working Capital | -385,000 |
Cash Flow
| Operating Cash Flow | -3.69M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is -9.84%, with operating and profit margins of -136.51% and -97.37%.
| Gross Margin | -9.84% |
| Operating Margin | -136.51% |
| Pretax Margin | -122.06% |
| Profit Margin | -97.37% |
| EBITDA Margin | -132.55% |
| EBIT Margin | -136.51% |
| FCF Margin | n/a |
Dividends & Yields
STO:FRAM.B does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -35.98% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |